Contribute Try STAT+ Today

Researchers reported Thursday that they have created a new model for studying treatments of Alzheimer’s disease — in rhesus macaque monkeys — that may speed the search for therapies that make an appreciable difference in the course of an illness that affects nearly 6 million Americans.

Despite three decades of intensive research on Alzheimer’s, and billions of dollars in funding, researchers have yet to find a way to prevent or cure, or even to slow, the disease as it rampages through aging brains. Some blame the mice.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Just like everything before, this is garbage. “Now we have a better mouse model,” “now we are studying tau as well as amyloid,” “now we are studying younger animals and humans,” “now we are jacking around data to try to get a blockbuster drug, “now we are scaring the bejesus out of the public to get more funding for bad research.”

    STAT is so good that I’m very disappointed to see such rah-rah unsubstantiated hype regarding a disease that has not budged despite decades of animal research. Hundreds of researchers have made careers and fortunes despite never prolonging the life of a single AD patient for even a single day. Disgraceful.

Comments are closed.